Navigation Links
Integrated neglected tropical disease control and elimination programs: A global health 'best buy'
Date:1/16/2013

WASHINGTON, D.C.January 17, 2013 A recently released report, entitled "Social and Economic Impact Review on Neglected Tropical Diseases," highlights links between neglected tropical diseases (NTDs) and socio-economic prosperity. Published by Hudson Institute's Center for Science in Public Policy, in partnership with the Global Network for Neglected Tropical Diseases, an initiative of the Sabin Vaccine Institute, the paper found NTD control and elimination efforts to be both inexpensive and highly effective, especially when paired with other major disease treatment efforts, making NTD programs one of the most cost-effective public health interventions available.

"Based on our efforts in compiling this review, we can say with confidence that NTD control and elimination is one of the best buys in global public health," said Dr. Jeremiah Norris, director of the Center for Science in Public Policy at Hudson Institute. "The crucial next step is to use this evaluation as a catalyst for prioritizing NTD programs worldwide."

NTDs are a group of parasitic and bacterial diseases that infect more than 1 billion people around the world, most of whom live below the poverty line. These diseases cause malnutrition and anemia, pregnancy complications, blindness, disfigurement and delays to physical and cognitive growth among children, often perpetuating the poverty of those they infect. For a cost of approximately 50 cents per person annually, a packet of pills can treat and protect against these diseases. Pharmaceutical companies donate most of the treatments and many programs use existing infrastructure, such as schools and community centers, to administer them.

Despite their wide-spread impact and low treatment cost, NTDs have been categorized as "other diseases" on the global health and development agenda and often exist in the shadow of better-known diseases such as HIV/AIDS, tuberculosis and malaria. Based on their findings, the report's authors outlined key recommendations for reducing the burden of NTDs and meeting elimination targets, including prioritizing integrated programs, pivoting from an exclusive health focus to a broader socio-economic context and expanding the role of corporate and public-private partnerships.

"This new report provides strong evidence of the larger socio-economic impact that NTDs have on infected communities," said Dr. Neeraj Mistry, managing director of the Global Network for Neglected Tropical Diseases. "By following the report's recommendations, we can build broader awareness and the political will necessary to put NTDs at the top of the global development agendaimproving the health and prosperity for more than a billion people currently suffering from these devastating diseases."


'/>"/>

Contact: Johanna Harvey
johanna.harvey@sabin.org
202-621-1691
Sabin Vaccine Institute
Source:Eurekalert

Related medicine news :

1. Qualicode and CellTrak Deliver Integrated Mobile Scheduling and Health Record Solution
2. Offenders need integrated, on-going, mental health care
3. Integrated Services Becomes Preferred Rental Provider for Rural/Metro Corporation
4. Physician-Patient Alliance for Health & Safety: The Path to a Safer PCA Pump - Improving Patient Safety with Integrated Capnography
5. Serious games could be integrated into surgical training subject to validation
6. Integrated diabetes management program provides rapid improvements in patient care
7. Beta Testing Opportunity for URAC Clinically Integrated Network Accreditation Program
8. AstraZeneca and DNDi to collaborate on drug screening for neglected tropical diseases
9. Funding for neglected global diseases research at UBC exceeds $20 million
10. Open access initiative reveals drug hits for deadly neglected tropical diseases
11. Millions of patients still waiting for medical breakthroughs against neglected diseases
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/18/2017)... ... ... the Snake”: an entertaining and moral-based short story about an unkind snake learning a ... Jr., a husband, father and grandfather who served as a U.S. Marine, U.S. Army ... for children and teens. My goal is to teach kids to use good judgement ...
(Date:8/17/2017)... NC (PRWEB) , ... August 17, 2017 , ... ... dental practice, is adding a new location in Goldsboro, NC to its family ... care that is Riccobene Associates’ trademark starting August 15, 2017. , Riccobene ...
(Date:8/17/2017)... (PRWEB) , ... August 17, 2017 , ... ... series, proudly announces that it will feature the National Council for Therapeutic Recreation ... for more information. , Established in 1981, NCTRC is a non-profit, international organization ...
(Date:8/17/2017)... MA (PRWEB) , ... August 17, 2017 , ... ... will come together on September 19, 2017 for Anti-Infectives Rx. This off-the-record networking ... B. Martin Conference Center at Harvard Medical School. , Industry leaders and decision ...
(Date:8/17/2017)... GA (PRWEB) , ... August 17, 2017 , ... ... to welcome Dr. Kristi Hebert to its newest location in East ... enthusiastic to have Dr. Hebert come aboard,” said Dr. Mark A. Haber, Georgia Urology’s ...
Breaking Medicine News(10 mins):
(Date:8/4/2017)... , Aug. 3, 2017  Agragen, LLC, ... company active in the biopharmaceutical, nutraceutical, and aquacultural ... development of its lead drug candidates, AGR131.  This ... proinflammatory cytokine from the blood of patients suffering ... and inflammatory bowel disease. ...
(Date:8/2/2017)... Aug. 2, 2017   Marshall County Hospital in Benton, Kentucky ... the risk of hospital-acquired infections (HAIs). The new addition, Tru-D SmartUVC , short for ... kill deadly pathogens such as C. diff , MRSA, MERS, Ebola and more. ... Tru-D SmartUVC ... Tru-D in action in a patient room ...
(Date:8/1/2017)... CerSci Therapeutics , a non-opioid drug development firm based ... notice from the National Institute on Drug Abuse (NIDA) ... has been awarded a Direct-to-Phase II Small Business Innovation ... an additional $1,000,000 to follow in 2018. These funds ... lead non-opioid drug candidate CT-044 to the Food and ...
Breaking Medicine Technology: